Hidden heart rhythm problems after stroke: can longer monitoring prevent a second stroke?
NCT ID NCT04371055
First seen Aug 28, 2026 · Last updated Aug 28, 2026
Summary
This trial tests whether intensive heart rhythm monitoring after a stroke can prevent another stroke. People who have had a stroke may have atrial fibrillation, a heart rhythm problem that comes and goes and is easy to miss. Researchers compare standard care with extra monitoring, either a 7-day Holter ECG repeated over time or a small implantable monitor that tracks the heart continuously. If atrial fibrillation is found, doctors can start blood thinners, which may lower the risk of a future stroke.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Intensive heart rhythm monitoring using 7-day Holter ECG or an implantable cardiac monitor, compared with standard care
- What this could lead to
- If it works, this could show that catching hidden atrial fibrillation after a stroke and starting blood thinners reduces the chance of another stroke.
- What could go wrong
- The trial is large but still experimental. More monitoring may find more atrial fibrillation, but it is not yet proven that this leads to fewer strokes, and implantable monitors carry small risks like infection or discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
5,227 people
The number who actually took part.
- Started
-
Jul 2020
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Recent ischemic stroke (sudden focal neurologic deficit lasting \> 24h consistent with the territory of a major cerebral artery) and/or a corresponding lesion on brain imaging within the last 30 days 2. Age ≥ 60 years 3. Patient without or with only slight disability (modified Rankin Scale score ≤ 2) before onset of stroke-related symptoms. 4. Written informed consent Exclusion Criteria: 1. Known history of atrial fibrillation/flutter or atrial fibrillation/flutter on admission ECG 2. Current indication or contraindication for oral anticoagulation at randomisation 3. Intracerebral bleeding in medical history 4. Patient scheduled for ECG-monitoring lasting \> 7 days (Holter-ECG, implanted loop recorder, etc.) 5. Implanted pacemaker device or cardioverter/ defibrillator 6. Patient not willing to be treated with oral anticoagulants 7. Carotid artery stenosis ipsilateral to the current ischemic stroke needing operation or intervention. 8. History of carotid endarterectomy or percutaneous intervention of cerebral artery within the last 30 days. 9. Life expectancy \<1 year for reasons other than stroke (e.g. metastatic cancer) 10. patients under legal supervision or guardianship 11. psychological/mental or other inabilities to supply required information (e.g. fill out the questionnaire due to dementia, language difficulties,...) or participate in the required tests 12. participation in other randomised interventional trials 13. suspected lack of compliance
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atrial fibrillation are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Albertinenkrankenhaus Hamburg
Hamburg, Germany
-
Asklepios Klinik Altona Hamburg
Hamburg, Germany
-
Asklepios Klinik Wandsbek, Hamburg
Hamburg, Germany
-
BG Klinikum, Unfall-KH Berlin gGmbH
Berlin, Germany
-
Bezirkskrankenhaus Günzburg
Günzburg, Germany
-
Carl-von-Basedow Klinikum Merseburg
Merseburg, Germany
-
Evangelisches Klinikum Bethel, Klinik für Neurologie
Bielefeld, 33611, Germany
-
Helios Dr. Horst Schmidt-Kliniken Wiesbaden
Wiesbaden, Germany
-
ISD München
München, Bavaria, Germany
-
Kliniken Südostbayern AG, Klinikum Traunstein
Traunstein, Germany
-
Klinikum Altenburger Land
Altenburg, Germany
-
Klinikum Aschaffenburg-Alzenau
Aschaffenburg, Germany
-
Klinikum Bremen Mitte
Bremen, Free Hanseatic City of Bremen, Germany
-
Klinikum Coburg, Medizinische Klinik für Innere Medizin und Kardiologie
Coburg, 96450, Germany
-
Klinikum Darmstadt
Darmstadt, Germany
-
Klinikum Frankfurt Höchst
Frankfurt, Germany
-
Klinikum Fulda
Fulda, Germany
-
Klinikum Höxter
Höxter, Germany
-
Klinikum Ibbenbüren
Ibbenbueren, Germany
-
Klinikum Minden
Minden, Germany
-
Klinikum Nürnberg
Nuremberg, Bavaria, 90471, Germany
-
Klinikum Osnabrück GmbH
Osnabrück, Germany
-
Klinikum Passau
Passau, Germany
-
Klinikum St. Georg Leipzig
Leipzig, Germany
-
Krankenhaus Martha-Maria Halle-Dölau
Halle, Germany
-
Kreisklinikum Siegen
Siegen, Germany
-
Medizinische Hochschule Hannover
Hanover, Germany
-
Nordwest-Krankenhaus Sanderbusch, Klinik für Neurologie
Sande, 26452, Germany
-
Rhön Klinikum Campus Bad Neustadt
Bad Neustadt an der Saale, Germany
-
Sozialstiftung Bamberg; Klinikum am Bruderwald
Bamberg, Germany
-
Städtisches Klinikum Dresden, Standort Friedrichstadt
Dresden, Germany
-
Städtisches Klinikum Lüneburg gemeinnützige GmbH
Lüneburg, Germany
-
University of Essen, Clinic for Neurology
Essen, 45147, Germany
-
University of Göttingen, Clinic for Neurology
Göttingen, 37075, Germany
-
University of Leipzig, Clinic for Neurology
Leipzig, Saxony, 04103, Germany
-
University of Mainz, Clinic for Neurology
Mainz, 55131, Germany
-
Universitätsklinikum Augsburg
Augsburg, Germany
-
Universitätsklinikum Bonn
Bonn, Germany
-
Universitätsklinikum Carl Gustav Carus
Dresden, Germany
-
Universitätsklinikum Erlangen
Erlangen, Germany
-
Universitätsklinikum Frankfurt
Frankfurt, Germany
-
Universitätsklinikum Gießen und Marburg GmbH
Giessen, Germany
-
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
-
Universitätsklinikum Heidelberg
Heidelberg, Germany
-
Universitätsklinikum Münster
Münster, Germany
-
Universitätsklinikum Tübingen
Tübingen, Germany
-
Universitätsklinikum Ulm
Ulm, Germany
-
Universitätsklinikum Würzburg
Würzburg, Germany
-
Vivantes Klinikum Neukölln Berlin
Berlin, State of Berlin, Germany
-
Vivantes Klinikum Spandau
Berlin-Spandau, Germany
-
Vivantes, Humboldt-Klinikum Berlin
Berlin, Germany
-
Ökumenisches Hainich Klinikum Mühlhausen
Mühlhausen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- High-resolution Contrast-Enhanced MRI of atrial fibrillation patients prior to FIRM ablation
- Safety and preliminary efficacy of NXL-001 in patients with ischemic stroke
- Apple watch vs. medical monitor: which better detects hidden heart rhythm problems?
- Can a new ultrasound catheter give doctors a better view inside the heart?
- Virtual reality rehab aims to bring stroke therapy home
- Blood clot markers may forecast stroke outcomes